
WBL Pharma Private Limited
About WBL Pharma Private Limited
Data last updated:
WBL Pharma Private Limited is a private limited company based in Varanasi, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 15 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24230UP2020PTC136288.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Servendra Kumar Singh and Rekha Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Varanasi, Uttar Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹29.66 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹9,100 (net margin -0.3%) and EBITDA of -₹9,100 (EBITDA margin -0.3%). Revenue has grown at a compounded annual rate (CAGR) of 64% over three years.
WBL Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-75-0003337).
Company details
Recognitions & Rankings of WBL Pharma
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-UP-75-0003337
Contact details
WBL Pharma Private Limited's registered office is in Varanasi, Uttar Pradesh.
- Registered AddressC/O Rekha Singh Sarai Dangari, Post Tikari, Varanasi, Uttar Pradesh, India – 221011
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of WBL Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of WBL Pharma Private Limited, buy the company report.
Financials of WBL Pharma Private Limited
FY 2025 filings availableWBL Pharma Private Limited reported revenue of ₹29.66 Lakh (up 173% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 64% over three years, including 173% growth in the latest year. EBITDA rose 96% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹9,100 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹9,100 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.3% | |||
| Net Profit Margin | -0.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of WBL Pharma Private Limited, buy the company report.
Board of directors of WBL Pharma Private Limited
WBL Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Servendra Kumar Singh | Director | 15 Oct 2020 | 6 Years 1 Months | Current |
| Rekha Singh | Director | 15 Oct 2020 | 6 Years 1 Months | Current |
Peer comparison
WBL Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ri Dev Rider Private Limited | ₹29.68 Lakh (FY 2024) | Shimla, Himachal Pradesh, India | ||||
| Vijaypath Retails Private Limited | ₹29.67 Lakh (FY 2018) | 7.0% | Kolkata, West Bengal, India | |||
| Tigerland Life Science Private Limited | ₹29.67 Lakh (FY 2024) | -2.0% | Kochi, Kerala, India | |||
| Penta Soled Power Industries Private Limited | ₹29.66 Lakh (FY 2016) | 62.0% | Indore, Madhya Pradesh, India | |||
| Mikado Laboratories Private Limited | ₹29.66 Lakh (FY 2025) | 8.0% | Mathura, Uttar Pradesh, India | |||
| WBL Pharma Private Limitedthis company | ₹29.66 Lakh (FY 2024) | -₹9,100 | -0.3% | 173.0% | Varanasi, Uttar Pradesh, India | |
| Ras Nirman & Developers Private Limited | ₹29.64 Lakh (FY 2025) | 27.0% | Kolkata, West Bengal, India | |||
| Dhananjay Power India Private Limited | ₹29.64 Lakh (FY 2019) | Jalgaon, Maharashtra, India | ||||
| Vaccinevalley Life Sciences Private Limited | ₹29.64 Lakh (FY 2024) | 4.0% | Chennai, Tamil Nadu, India | |||
| Hosemasters Industrial Connectors Private Limited | ₹29.63 Lakh (FY 2025) | -9.0% | Hyderabad, Telangana, India | |||
| Hexenby Traders Private Limited | ₹29.63 Lakh (FY 2024) | -19.0% | Bengaluru, Karnataka, India |
To see the full peer comparison of WBL Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving WBL Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for WBL Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for WBL Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
WBL Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Rekha Singh was appointed as Director on 15 Oct 2020.
Frequently asked questions
WBL Pharma is an active private limited company based in Varanasi, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 15 October 2020 (6+ years old) and is registered under CIN U24230UP2020PTC136288.
WBL Pharma has 2 current directors:
- Servendra Kumar Singh - Director
- Rekha Singh - Director
The latest financial statements of WBL Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of WBL Pharma is U24230UP2020PTC136288. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
WBL Pharma was incorporated on 15 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of WBL Pharma by revenue are Ri Dev Rider Private Limited, Vijaypath Retails Private Limited, Tigerland Life Science Private Limited, Penta Soled Power Industries Private Limited, Mikado Laboratories Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Rekha Singh was appointed as Director on 15 Oct 2020. Servendra Kumar Singh was appointed as Director on 15 Oct 2020.
Yes, WBL Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, WBL Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-75-0003337).
The registered office of WBL Pharma is at CO Rekha Singh Sarai Dangari, Post Tikari, Varanasi, Uttar Pradesh, India – 221011.
WBL Pharma operates in the chemicals industry, in the manufacturing segment.

